Data-to-care programs utilize surveillance data to identify persons who are out of HIV care, re-engage them in care, and improve HIV care outcomes.
The Cooperative Re-engagement Control Trial (CoRECT) employed a data-to-care collaborative model between health departments and HIV care providers. The health departments in Connecticut (CT), Massachusetts (MA), and Philadelphia (PHL) collaborated with HIV clinics to identify newly out-of-care patients and randomize them to receive usual linkage and engagement in care services (standard-of-care control arm) or health department-initiated active re-engagement services (intervention arm). We used a microcosting approach to identify the activities and resources involved in the CoRECT intervention and quantified the labor and non-labor costs. The cost data were collected at start-up and recurrent phases of the trial to incorporate potential variation in the intervention costs. We estimated costs and cost-effectiveness of re-engagement in care for each project site from the health care provider perspective.
The CoRECT trial in CT, MA and PHL randomly assigned on average 327, 315, and 305 participants per year either to the intervention arm (n=166, 159, and 155) or the standard-of-care arm (n=161, 156, and 150), respectively. Of those randomized, the number of participants re-engaged in care within 90 days in the intervention and standard-of-care arms were 85 and 67 in CT, 84 and 69 in MA, and 98 and 64 in PHL. The additional number of participants re-engaged in care in the intervention arm compared with those in the standard-of-care arm was 18 (CT), 15 (MA), and 34 (PHL). We estimated annual total intervention cost at $490,040 in CT, $473,297 in MA, and $439,237 in PHL. The average cost per participant enrolled was $2,952, $2,977, and $2,834, and the average cost per participant re-engaged in care was $5,765, $5,634, and $4,482 in CT, MA, and PHL, respectively. We estimated an incremental cost per participant re-engaged in care at $27,224 (CT), $31,553 (MA), and $12,919 (PHL).
The costs of the collaborative re-engagement in HIV care intervention are comparable with other similar interventions, suggesting a potential for its cost-effectiveness. Further analysis may account for site-specific variation in program implementation and cost sharing between health department and clinics.